Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer
Closed
Other
This study is looking at treating prostate cancer with radiofrequency ablation (RFA) using a new device called Encage. Radiofrequency is a type of electrical energy. Ablation means destroying completely. The electrical energy heats up the tumour and kills the cancer cells. You have RFA through a probe that goes through your skin into the cancer.
If prostate cancer has not spread outside the prostate gland it is called localised prostate cancer. In this situation, there are different treatments that men can have, such as surgery or radiotherapy. But treatment to the whole prostate gland often causes side effects such as problems getting an erection, urinary problems, diarrhoea and pain or bleeding from the back passage.
Recruitment start: 12 May 2015
Recruitment end: 24 March 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Hashim Uddin Ahmed
TROD Medical, Belgium
TROD Medical US, LLC
University College London (UCL)
Last reviewed: 5 June 2016
CRUK internal database number: 13001